Dean Eliott, M.D.
|Associate Director, Retina Service|
Macular Degeneration Unit
Mass. Eye and Ear
243 Charles Street
Boston, MA 02114
Mass. Eye and Ear Retina Consultants
3 Woodland Road, Suite 210
Stoneham, MA 02180
|M.D.||Vanderbilt University School of Medicine|
|Residency||Ophthalmology, Wilmer Eye Institute/Johns Hopkins Hospital|
|Fellowship||Vitreoretinal Surgery, Duke University Medical Center|
|Teaching Affiliation||Stelios Evangelos Gragoudas Associate Professor of Ophthalmology, Harvard Medical School|
After receiving his medical training from Vanderbilt University School of Medicine, Dr. Eliott completed his ophthalmology residency at Wilmer Eye Institute/Johns Hopkins Hospital. This was followed by a vitreoretinal fellowship at Duke University where he was also Chief Resident and a faculty member. Dr. Eliott then spent twelve years on the faculty at Kresge Eye Institute in Detroit where he was Director of the Retina Service and Retina Fellowship Director. Before coming to Mass. Eye and Ear, Dr. Eliott was Professor of Ophthalmology, Director of Clinical Affairs, and Director of Vitreoretinal Fellowship at the University of Southern California Keck School of Medicine’s Doheny Eye Institute in Los Angeles.
Dr. Eliott co-directs the Diabetic Eye Disease Center of Excellence at Harvard Medical School—a multidisciplinary collaboration among clinicians and scientists who are pooling their knowledge and resources with the goal of advancing breakthroughs in treatment for patients with diabetic eye disease. Additionally, he plays an important role training ophthalmology residents and fellows in the clinic and in the operating room as Director of the Retina Fellowship and Co-Director of Mass. Eye and Ear’s Vitrectomy Course. He also is a sought after regional, national, and international speaker.
In addition, Dr. Eliott has established a focused translational research program, where he is investigating ways to improve the diagnoses and outcomes for proliferative vitreoretinopathy; age-related macular degeneration; diabetic macular edema; and complex vitreoretinal surgical conditions, such as retinal detachment. As a clinical innovator and clinician scientist, Dr. Eliott is particularly interested in implantable and sustained-release steroid devices, vision-restoring electrical devices, and stem cell therapy. He continually receives research funding from the government and industry, and he has received several honors, including an American Academy of Ophthalmology Achievement Award, the Crystal Apple Teaching Award from the Young Physicians group of the American Society of Retina Specialists, and the Vitreous Society Honor Award.
Research and Clinical Interests
Diabetic retinopathy, macular degeneration, retinal detachment, surgery for retina-vitreous disorders and ocular trauma
For a full publication list, please see his CV.
Retinal detachment after open globe injury. Stryjewski TP, Andreoli CM, Eliott D. Ophthalmology. 2014 Jan;121(1):327-333.
Fellow eye vitrectomy for proliferative diabetic retinopathy in an inner city population. Hwang JC, Sharma AG, Eliott D. Br J Ophthalmol. 2013 Mar;97(3):297-301.
Angiofibrotic response to VEGF inhibition in diabetic retinal detachment: report no. 1. Sohn EH, He S, Kim LA, Salehi-had H, Javaheri M, Spee C, Dustin L, Hinton DR, Eliott D. Arch Ophthalmol. 2012 Sep;130(9):1127-34.
Interim results from the international trial of Second Sight’s visual prosthesis. Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Sahel JA, Stanga PE, Cideciyan AV, Duncan JL, Eliott D, Filley E, Ho AC, Santos A, Safran AB, Arditi A, Del Priore LV, Greenberg RJ; Argus II Study Group. Ophthalmology. 2012 Apr;119(4):779-788.
Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Pearson PA, Comstock TL, Ip M, Callanan D, Morse LS, Ashton P, Levy B, Mann ES, Eliott D. Ophthalmology. 2011 Aug;118(8):1580-1587.